Alta Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.05M Sell
2,539
-21
-0.8% -$21.5K 0.83% 28
2026
Q1
$2.35M Sell
2,560
-12
-0.5% -$12.2K 0.76% 27
2025
Q4
$2.76M Buy
2,572
+31
+1% +$29.6K 0.92% 21
2025
Q3
$1.94M Sell
2,541
-522
-17% -$388K 0.69% 31
2025
Q2
$2.39M Hold
3,063
1.13% 18
2025
Q1
$2.53M Buy
3,063
+2
+0.1% +$1.66K 1.16% 21
2024
Q4
$2.36M Buy
3,061
+16
+0.5% +$13.2K 1.03% 22
2024
Q3
$2.7M Sell
3,045
-7
-0.2% -$6.29K 1.23% 19
2024
Q2
$2.76M Buy
3,052
+4
+0.1% +$3.2K 1.38% 18
2024
Q1
$2.37M Hold
3,048
1.21% 20
2023
Q4
$1.78M Buy
3,048
+2
+0.1% +$1.17K 0.99% 24
2023
Q3
$1.64M Buy
3,046
+297
+11% +$153K 1% 28
2023
Q2
$1.29M Buy
2,749
+36
+1% +$15.1K 0.76% 35
2023
Q1
$932K Buy
2,713
+65
+2% +$21.9K 0.59% 51
2022
Q4
$969K Sell
2,648
-27
-1% -$9.57K 0.65% 41
2022
Q3
$865K Hold
2,675
0.62% 42
2022
Q2
$871K Buy
+2,675
New +$803K 0.6% 43

Other funds holding LLY

Alta Wealth Advisors's LLY Position: Q2 2026 in Review

Alta Wealth Advisors reduced its Eli Lilly (LLY) stake by 0.82% in Q2 2026, selling an estimated $21.5K and leaving 2,539 shares worth $3.05M. The position accounts for 0.83% of the portfolio, ranked #28.

Alta Wealth Advisors first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alta Wealth Advisors held 2,539 shares of Eli Lilly worth $3.05M as of Q2 2026.
  • Alta Wealth Advisors sold 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
  • Eli Lilly made up 0.83% of Alta Wealth Advisors's portfolio in Q2 2026, its #28 holding.
  • Alta Wealth Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alta Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.